Bioabsorbable Therapeutics

Bioabsorbable Therapeutics, Inc. was a medical device company based in Menlo Park, California, that specialized in the development of fully bioabsorbable stent systems for treating vascular diseases. Founded in 2004, the company utilized proprietary anti-inflammatory polymers to create stents and coatings designed to provide temporary mechanical support to blood vessels before being naturally resorbed by the body. Its lead product candidates included the Whisper coronary stent system, a sirolimus-eluting bioabsorbable scaffold, and the Unison peripheral stent system. The company's technology aimed to address the limitations of permanent metallic stents, such as chronic inflammation and late-stage thrombosis. Bioabsorbable Therapeutics was acquired by MultiCell Corporation in 2010 to integrate its polymer technology into a broader portfolio of therapeutic devices.